Hematologic Neoplasms

Top drugs studied for this disease

CLINICAL_TRIALS withdrawal · 2026-02-24
Clinical Trial Update: A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation [Phase 2]
Phase 2 trial of ASTX727 (oral decitabine/cedazuridine) for hematologic neoplasms after allogeneic stem cell transplantation has been withdr…
CLINICAL_TRIALS withdrawal · 2024-09-03
Clinical Trial Update: Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy
The trial investigating immunological, neurocognitive, activity, and driving fitness outcomes in CAR-T cell therapy for hematologic neoplasm…